Acne
MONDO:0011438An inflammatory process of the sebaceous glands which is characterized by comedones, nodules, papules and/or pustules on the skin.
Also known as: acne, acne (disease), acne varioliformis, acne vulgaris, acne, adult
94 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New acne gel put to the test for Year-Long safety
Disease control OngoingThis study is testing whether a new gel applied daily for up to 52 weeks is safe for people with acne. About 400 participants will use the gel on their face and upper body and visit the clinic regularly for checkups. The main goal is to track any side effects, not to measure how …
Phase: PHASE3 • Sponsor: PPM Services S.A. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Zapping acne with radio waves: new device tested
Disease control OngoingThis study tests a device that uses fractional radiofrequency energy to treat moderate to severe acne. Thirty people aged 18 to 25 will receive the treatment. Researchers will check if acne improves and how satisfied participants are with the results.
Phase: NA • Sponsor: Pollogen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Acne cream aims to shrink oil glands in new study
Disease control OngoingThis study tests whether a cream called clascoterone (Winlevi) can shrink oil glands and change the oil on the face in people with acne. Ten adults with oily skin and moderate acne will use the cream twice daily for 3 months. Researchers will take small skin samples to see if the…
Phase: PHASE4 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New cream aims to keep acne away after strong medication
Disease control OngoingThis study tests a cosmetic cream (RV3278B-OS0386) to see if it can stop acne from returning after a full course of oral isotretinoin. About 102 adults with clear or almost clear skin after isotretinoin will use the cream or a control product twice daily for 12 months. The main g…
Phase: NA • Sponsor: Pierre Fabre Dermo Cosmetique • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Pharmacists take on heart disease: new study tests community-based risk reduction
Disease control OngoingThis study tests whether a pharmacist-led program can help people reduce their risk of heart disease. Over 1,000 adults with conditions like diabetes, high blood pressure, or obesity are taking part. Pharmacists use a step-by-step guide to assess risk and support lifestyle change…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New light therapy could zap stubborn acne without pills
Disease control OngoingThis study tests a treatment called photodynamic therapy (PDT) for adults with moderate to severe acne. A gel called Ameluz® is applied to the face, then activated with a special red light. The goal is to see if this combination reduces acne lesions better than a placebo. About 1…
Phase: PHASE2 • Sponsor: Biofrontera Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Antifungal cream could be new acne treatment
Disease control OngoingThis study tests whether a common antifungal cream, ketoconazole, can treat mild acne as well as a standard retinoid cream, adapalene. Fifty-two people with mild acne will use one of the two creams for 12 weeks. Researchers will count pimples and check for side effects to see if …
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a Fat-Derived injection erase acne scars?
Symptom relief OngoingThis study tests whether an injection made from human fat cells (Tience®) can safely reduce moderate to severe acne scars. Twenty adults aged 18-40 with scars on their cheeks will receive three treatments on one side of the face over three months. Doctors and participants will tr…
Phase: NA • Sponsor: Linio Biotech Oy • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Which pill works better for acne? new study compares hormone therapy vs antibiotic
Symptom relief OngoingThis study compares two common acne pills for women: spironolactone (a hormone blocker) and doxycycline (an antibiotic). About 350 women aged 16-40 with moderate to severe acne will take one of the two medicines for several weeks. Researchers will count how many pimples clear up …
Phase: PHASE4 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New acne cream could help transgender men on testosterone without interfering with hormones
Symptom relief OngoingThis study tests a prescription cream (clascoterone) to treat acne caused by testosterone therapy in transgender men. About 18 participants will use the cream daily for 3 months to see if it reduces pimples without affecting their hormone levels. The goal is to provide a safe acn…
Phase: PHASE1, PHASE2 • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New acne gel put to the test in everyday life
Symptom relief OngoingThis study follows about 200 people aged 12 and older in Canada who are using a prescription gel containing clindamycin, adapalene, and benzoyl peroxide for acne. Researchers want to see how satisfied patients are, how well they stick to the treatment, and how it affects their qu…
Sponsor: Bausch Health Americas, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
New acne gel shows promise in large trial
Symptom relief OngoingThis Phase 3 trial tests a new gel (N-Acetyl-GED-0507-34-LEVO) applied once daily for 12 weeks to reduce acne lesions on the face and trunk. About 400 participants will be randomly assigned to receive either the active gel or a placebo. Researchers will measure changes in lesion …
Phase: PHASE3 • Sponsor: PPM Services S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New acne gel shows promise in large trial
Symptom relief OngoingThis Phase 3 trial tests a new gel called N-Acetyl-GED-0507-34-LEVO for acne vulgaris. About 400 people will apply the gel or a placebo daily for 12 weeks. Researchers will count pimples and rate skin clarity to see if the gel works better than placebo.
Phase: PHASE3 • Sponsor: PPM Services S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Probiotics plus antibiotics: a new hope for acne sufferers?
Symptom relief OngoingThis study tests whether adding probiotics to the antibiotic azithromycin works better than azithromycin alone for treating mild to moderate acne. Sixty participants with 20 to 50 acne lesions will be treated and their lesion counts measured before and after. The goal is to see i…
Phase: PHASE4 • Sponsor: Hayatabad Medical Complex • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Ginger patch takes on acne: a natural approach?
Symptom relief OngoingThis study tests a ginger extract patch for mild to moderate acne in 26 women aged 15–45. Each participant applies the patch to one side of the face after using a standard tretinoin cream, while the other side gets only the cream. Researchers count acne lesions and check skin bac…
Phase: PHASE2, PHASE3 • Sponsor: Hasanuddin University • Aim: Symptom relief
Last updated Jun 26, 2026 17:06 UTC
-
NIH launches Long-Term observation of inflammatory diseases
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows up to 500 people with acute or chronic inflammatory disorders, such as infections or immune problems, over time. Researchers will monitor participants with standard tests and may screen them for other studies. The goal is to better understand these conditions a…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists hunt for genetic clues in blood and urine to personalize lung cancer care
Knowledge-focused OngoingThis study collects blood, urine, and tissue samples from 330 adults with advanced lung or head and neck cancer to improve precision medicine. Researchers will analyze genetic changes in these samples and grow some tumors in mice to compare DNA. The goal is to refine liquid biops…
Phase: NA • Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Acne antibiotics may reshape your Body's bacteria
Knowledge-focused OngoingThis study looks at how the antibiotic doxycycline changes the bacteria on the skin and in the gut of people with acne. Researchers will compare these changes between acne patients and healthy volunteers. The goal is to better understand the link between acne, antibiotics, and th…
Phase: PHASE1, PHASE2 • Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
AI vs. skin doctors: who diagnoses better?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether artificial intelligence (AI) can match a dermatologist's diagnosis when a general practitioner sends in photos and questions about a patient's skin condition. Researchers will compare the AI's diagnosis to the dermatologist's for about 1000 adults. The…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Acne Patients' medication habits under the microscope
Knowledge-focused OngoingThis study tracks how consistently 72 adults with acne use their prescribed topical medications. Researchers measure adherence by weighing bottles and using electronic monitors to count doses. The goal is to identify barriers like cost, side effects, or forgetfulness that cause p…
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Top dermatologists unite to tame acne treatment chaos
Knowledge-focused ENROLLING_BY_INVITATIONThis study brings together 15 expert dermatologists to agree on the best ways to use isotretinoin, a powerful acne medication. The goal is to create clear, practical guidelines on when to prescribe it, how to dose it, and how to monitor side effects. The study does not test a new…
Sponsor: Venus Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC